The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
Open accessAbstract
Histone-modifying enzymes play essential roles in physiological and aberrant gene regulation. Since histone deacetylases (HDACs) are promising targets of cancer therapy, it is important to understand the mechanisms of HDAC regulation. Selective modulators of HDAC isoenzymes could serve as efficient and well-tolerated drugs. We show that HDAC2 undergoes basal turnover by the ubiquitin-proteasome pathway. Valproic acid (VPA), in addition to selectively inhibiting the catalytic activity of class I HDACs, induces proteasomal degradation of HDAC2, in contrast to other inhibitors such as trichostatin A (TSA). Basal and VPA-induced HDAC2 turnover critically depend on the E2 ubiquitin conjugase Ubc8 and the E3 ubiquitin ligase RLIM. Ubc8 gene expression is induced by both VPA and TSA, whereas only TSA simultaneously reduces RLIM protein levels and therefore fails to induce HDAC2 degradation. Thus, poly-ubiquitination and proteasomal degradation provide an isoenzyme-selective mechanism for downregulation of HDAC2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibition of histone deacetylase (HDAC) increases acetylation of H4 and disrupts the interaction between the locus and RNA polymerase II, leading to the suppression of PU.1 transcription in murine microglia [35, 36].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [36]
In the citing paper
“Valproic acid treatment, which selectively inhibits the catalytic activity of class I HDACs and induces proteasomal degradation of HDAC2, of primary adult human microglia reduces phagocytic capacity and expression of PU.1 and CD45, suggesting the its regulation of microglial phagocytosis via epigenetic mechanism [36-38].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [36]
In the citing paper
“Acetylation of histone H4 on the promoter and intron-1 region of the PU.1 locus are tightly regulated for allowing the interaction between the locus and RNA polymerase II.”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [36]
In the citing paper
“suggesting the its regulation of microglial phagocytosis via epigenetic mechanism [36-38].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
Glickman, M. H., & Ciechanover, A. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00027.2001 · Cited by 4,296
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Göttlicher, M., Minucci, S., Zhu, P., Krämer, O. H., Schimpf, A., Giavara, S., Sleeman, J. P., Coco, F. L., Nervi, C., Pelicci, P. G., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,930
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,544
Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase
Nagy, L., Kao, H.-Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80218-4 · Cited by 1,230
Protein regulation by monoubiquitin
Hicke, L. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056583 · Cited by 1,227
A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression
Heinzel, T., Lavinsky, R. M., Mullen, T.-M., Söderström, M., Laherty, C. D., Torchia, J., Yang, W., Brard, G., Ngo, S. D., Davie, J., et al. (1997) · Nature · doi:10.1038/387043a0 · Cited by 1,210
Cited by
Sorted by citations
Items 401–500 of 522
Fontes‐Dutra, M., Marafiga, J. R., Santos‐Terra, J., Deckmann, I., Schwingel, G. B., Rabelo, B. F., de Moraes, R. K., Rockenbach, M. K., Pasquetti, M. V., Gottfried, C., et al. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15893 · Cited by 11
Clinical Applications of Histone Deacetylase Inhibitors
Thomas, S., Miller, A., Thurn, K. T., & Münster, P. N. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375709-8.00037-x · Cited by 9
Interfering with the Dynamics of Estrogen Receptor-Regulated Transcription
Johnsen, S. A., Kangaspeska, S., Reid, G., & Gannon, F. (2007) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2006_013 · Cited by 9
Pharmacodynamic markers for histone deacetylase inhibitor development
Heinzel, T., & Krämer, O. H. (2007) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2008.06.003 · Cited by 9
Yan, T., Leng, Y., Yang, X., Gong, Y., Sun, H., Wang, K., Xu, W., Zheng, Y., Naren, D., & Shi, R. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.02.004 · Cited by 9
Molecularly Targeted Therapy in Acute Myeloid Leukemia
BERNASCONI, P. P., Boni, M., Cavigliano, P. M., Calatroni, S., Giardini, I., Rocca, B., Zappatore, R., Caresana, M., & Quarna, J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1322.049 · Cited by 9
Valproic Acid in Prevention and Treatment of COVID-19Preprint
Singh, S., & Singh, K. K. (2020) · doi:10.22541/au.158931086.64128149 · Cited by 9
Activity-based probe profiling of RNF12 E3 ubiquitin ligase function in Tonne-Kalscheuer syndrome
Bustos, F., Mathur, S., Espejo-Serrano, C., Toth, R. L., Hastie, C. J., Virdee, S., & Findlay, G. M. (2022) · Life Science Alliance · doi:10.26508/lsa.202101248 · Cited by 8
Regulation of LIM-domain-binding 1 protein expression by ubiquitination of Lys134
Howard, P. W., Jue, S. F., Ransom, D. G., & Maurer, R. A. (2010) · Biochemical Journal · doi:10.1042/bj20091461 · Cited by 8
(Epi)genetic control of secondary seed dormancy depth and germination in Capsella bursa-pastoris
Gómez-Cabellos, S., Toorop, P. E., Fernández‐Pascual, E., Iannetta, P. P. M., Pritchard, H. W., & Visscher, A. M. (2022) · Seed Science Research · doi:10.1017/s0960258522000265 · Cited by 8
Plasticity-augmented psychotherapy for refractory depressive and anxiety disorders
Choi, K., & Kim, Y. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.04.003 · Cited by 8
Valproic Acid in Prevention and Treatment of COVID-19Preprint
Singh, S., & Singh, K. K. (2020) · doi:10.22541/au.159000338.83671779 · Cited by 8
Wang, Z., Wang, M., Luo, Z., Fu, Y., Zhu, X., Li, D., Jiang, W., Cheng, X., Cai, C., Zhu, X., et al. (2025) · International Dental Journal · doi:10.1016/j.identj.2025.100850 · Cited by 7
Lam, Y. M., Chan, Y. F., Chan, L. C., & Ng, R. K. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-2075-2 · Cited by 7
Glycosphingolipid GM3 prevents albuminuria and podocytopathy induced by anti-nephrin antibody
Kawashima, N., Naito, S., Hanamatsu, H., Nagane, M., Takeuchi, Y., Furukawa, J., Iwasaki, N., Yamashita, T., & Nakayama, K.-I. (2022) · Scientific Reports · doi:10.1038/s41598-022-20265-w · Cited by 7
Márquez-Cantudo, L., Ramos, A., Coderch, C., & de Pascual‐Teresa, B. (2021) · Molecules · doi:10.3390/molecules26185606 · Cited by 8
Chlamydia pneumoniaeand Acute Coronary Syndrome
Wong, B. Y. L., & Gnarpe, J. (2005) · New England Journal of Medicine · doi:10.1056/nejm200508043530518 · Cited by 7
Ubiquitin proteasome system (UPS): a crucial determinant of the epigenetic landscape in cancer
Roy, S., & Ghosh, M. K. (2025) · Epigenomics · doi:10.1080/17501911.2025.2501524 · Cited by 7
Stakišaitis, D., Kapočius, L., Tatarūnas, V., Gečys, D., Mickienė, A., Tamošuitis, T., Ugenskienė, R., Vaitkevičius, A., Balnytė, I., & Lesauskaitė, V. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16030409 · Cited by 7
PJA2 Suppresses Colorectal Cancer Progression by Controlling HDAC2 Degradation and Stability
Chen, Z., Peng, C., Jin, C., Wang, Y., Wang, T., Yang, P., Peng, W., Sun, Q., Xu, H., Nie, H., et al. (2025) · Advanced Science · doi:10.1002/advs.202401964 · Cited by 6
Emerging targets and translational challenges in treating paclitaxel-induced peripheral neuropathy
Krishna, S. S., Shaji, N., Kumar, N. V., Das, A., Sabitha, M., Biswas, L., & Pavithran, K. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10938-w · Cited by 7
The effect of histone deacetylase inhibitors on the efficiency of the CRISPR/Cas9 system
Bjornson, Y. M., Huang, C. Y., Rollins, J. L., Castañeda, G. A. L., Kaur, N., Yamamoto, E., & Johnston, J. M. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101513 · Cited by 7
Kumar, P., Neelamegam, K., Ramasamy, C., Samivel, R., Xia, H., Kapusta, D. R., & Pandey, K. N. (2024) · The FASEB Journal · doi:10.1096/fj.202400714r · Cited by 6
Inhibition of RING1B alters lineage specificity in human embryonic stem cells
Desai, D., Khanna, A., & Pethe, P. S. (2020) · Cell Biology International · doi:10.1002/cbin.11325 · Cited by 6
Histone Deacetylase Inhibitors in APL and Beyond
Petrie, K. R., Prodromou, N. V., & Zelent, A. (2007) · Springer eBooks · doi:10.1007/978-3-540-34594-7_10 · Cited by 7
Drug discovery for spinal muscular atrophy
Wirth, B., Rießland, M., & Hahnen, E. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.4.437 · Cited by 6
Fagundes, S. B. R. (1999) · Revista Neurociências · doi:10.34024/rnc.2008.v16.8650 · Cited by 6
Epigenetic Therapies in Endocrine-Related Cancers: Past Insights and Clinical Progress
Varun, D., Haque, M., Jackson-Oxley, J., Thompson, R., Kumari, A. A., Woodcock, C. L., Harris, A. E., Madhusudan, S., Rakha, E. A., Rutland, C. S., et al. (2025) · Cancers · doi:10.3390/cancers17152418 · Cited by 6
Kowalski, T. W., Dupont, Á. D. V., Rengel, B. D., Sgarioni, E., Gomes, J. D. A., Fraga, L. R., Schüler‐Faccini, L., & Vianna, F. S. L. (2019) · Reproductive Toxicology · doi:10.1016/j.reprotox.2019.07.015 · Cited by 5
Teafatiller, T., Subramanian, S., Marquez, F. E., Kitazawa, M., & Subramanian, V. S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120944 · Cited by 5
Nam, Y. S., Choi, Y. M., Lee, S., & Cho, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065695 · Cited by 5
Epigenetic Modification of MicroRNAs
Pal, D., Ghatak, S., & Sen, C. K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405544-5.00003-4 · Cited by 6
Duan, H., Ma, D., Zhou, K., Wang, T., Zhang, Y., Li, Y., Wu, J., Hua, Y., & Wang, C. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.206352 · Cited by 5
Megakaryocyte lineage development is controlled by modulation of protein acetylation
Bartels, M., Govers, A. M. A. P., Polak, R., Vervoort, S. J., van Boxtel, R., Pals, C. E. G. M., Bierings, M., van Solinge, W. W., Egberts, T. C. G., Nieuwenhuis, E. E. S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196400 · Cited by 5
HDAC2 Cytoplasmic Sequestration Potentiates Keratinocyte Terminal Differentiation
Bakin, R. E., & Jung, M. O. (2008) · The Open Cell Development & Biology Journal · doi:10.2174/1874085500801010001 · Cited by 4
mTOR and HDAC2 are simultaneously activated during electrically induced kindling of seizures
Chmielewska, N., Wawer, A., Osuch, B., Maciejak, P., & Szyndler, J. (2022) · Epilepsy Research · doi:10.1016/j.eplepsyres.2022.106991 · Cited by 4
Arakelyan, J., Rusanov, D. A., Chang, M. R., Asaturova, A. V., Kireeva, G. S., Alshehri, M. M., Ang, W. H., & Babak, M. V. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214899 · Cited by 5
Watson, A. L., Shah, P., Lee, D., Liang, S., Joshi, G., Metitiri, E. E., Chowdhury, W. H., Bacich, D. J., Dube, P. H., Yan, X., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0307154 · Cited by 4
Xu, M., Qian, J., Si, L., Qu, X., & Li, J. (2019) · Cellular Reprogramming · doi:10.1089/cell.2018.0071 · Cited by 4
The Ubiquitin/SUMO Pathway and Radial Ray Deficiency Syndromes
Al-Qattan, M. M. (2012) · Annals of Plastic Surgery · doi:10.1097/sap.0b013e318236452b · Cited by 4
Putative biological predictors of treatment response in bipolar disorders
Gonzalez, S., Williams, A. J., Blacker, C. J., Voort, J. L. V., Schak, K. M., Nemeroff, C. B., Widge, A. S., & Tohen, M. F. (2016) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2016.11.003 · Cited by 5
Histone Deacetylase Activity and COPD
Lin, A. Y. (2005) · New England Journal of Medicine · doi:10.1056/nejm200508043530519 · Cited by 4
Kalle, A. M., & Wang, Z. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/578062 · Cited by 4
Piorczynski, T. B., Calixto, J., Henry, H. C., England, K., Cowley, S., Hansen, J. M., Hill, J. T., & Hansen, J. M. (2024) · Antioxidants · doi:10.3390/antiox13050560 · Cited by 3
Analysis of HDACi-Coupled Nanoparticles: Opportunities and Challenges
Kühne, M., Hofmann, S., Lindemann, H., Cseresnyés, Z., Dzierza, A., Schröder, D., Godmann, M., Koschella, A., Eggeling, C., Fischer, D., et al. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2788-4_9 · Cited by 3
Antoniou, T., Yao, Z., Camacho, X., Mamdani, M., Juurlink, D. N., & Gomes, T. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3761 · Cited by 3
Valproic acid decreases the reparation capacity of irradiated MOLT-4 cells
Muthná, D., Vávrová, J., Lukášová, E., Tichý, A., Knížek, J., Köhlerová, R., Mazánková, N., & Řezáčová, M. (2012) · Molecular Biology · doi:10.1134/s0026893312010141 · Cited by 3
Anupriya, S., Chakraborty, A., & Patnaik, S. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08215-6 · Cited by 3
How does the Xist activator Rlim/Rnf12 regulate Xist expression?
Wang, F., Mehta, P., & Bach, I. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230573 · Cited by 3
Neurological Complications of Targeted Therapies
Forst, D. A., & Wen, P. Y. (2017) · Springer eBooks · doi:10.1007/978-3-319-57901-6_16 · Cited by 3
Castillo-Juárez, P., Sanchez, S. C., Chávez-Blanco, A. D., Mendoza-Figueroa, H. L., & Correa‐Basurto, J. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620666200728125356 · Cited by 3
When Genetic and Environmental Factors Meet in Modelling Autism
Pettie, M. A. (2020) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17148212.v1 · Cited by 4
Epigenetic transcriptional repression of tumor suppresor genes and its reversion by drugs.
Villar‐Garea, A. (2005) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia) · Cited by 2
Li, C. L., Ou, M., Jiang, G., Zheng, G., & Jiang, Y. (2026) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70349 · Cited by 3
Valproic Acid Accelerates Neural Outgrowth during Dorsal Root Ganglia Neurogenesis In Vitro
Wiens, D. J., Bergan, H. M., Walter, O. S., McGinley, A., & Ahlrichs, B. (2019) · Annals of Behavioral Neuroscience · doi:10.18314/abne.v2i1.1607 · Cited by 1
Microrchidia 2/histone deacetylase 1 complex regulates E-cadherin gene expression and function
Thomas, L., Chutani, N., Krishna, R., Nair, S. A., Yellapu, N. K., Karyala, P., & Pakala, S. B. (2023) · Biochemical Journal · doi:10.1042/bcj20230304 · Cited by 2
Luhach, K., Sharma, P., Sharma, N., Dhiman, N., Kharkwal, H., & Sharma, B. (2023) · Springer eBooks · doi:10.1007/978-3-031-42383-3_3 · Cited by 3
Anti-teratogenic potential and curtailing toxicity of valproic acid
Kumar, A. (2018) · MOJ Toxicology · doi:10.15406/mojt.2018.04.00114 · Cited by 2
Clinical Applications of Histone Deacetylase Inhibitors
Pacaud, R., García, J., Thomas, S., & Münster, P. N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91909-8.00002-5 · Cited by 2
Valproate Mediated Proteasome Dysfunctions Induce Apoptosis
Kinger, S., Jagtap, Y. A., Dubey, A. R., Kumar, P., Choudhary, A., Karmakar, S., Lal, G., Prajapati, V. K., Jha, H. C., Gutti, R. K., et al. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202300421 · Cited by 2
Crosstalk Between Ubiquitination and Acetylation in the Parkinson's Disease
Sagar, M., & Kumar, P. (2022) · International Conference on Advanced Computing and Communication Systems (ICACCS) · doi:10.1109/icaccs54159.2022.9785234 · Cited by 1
Loss of Notch dimerization perturbs intestinal homeostasis by a mechanism involving HDAC activity
Dai, Q., Preuße, K., Yu, D., Kovall, R. A., Thorner, K., Lin, X., & Kopan, R. (2024) · PLoS Genetics · doi:10.1371/journal.pgen.1011486 · Cited by 2
From bench to bedside: Targeting epigenetics for cancer therapy
Li, G., & Fang, J. (2011) · Clinical Oncology and Cancer Research · doi:10.1007/s11805-011-0580-x · Cited by 1
Optimising the transient expression of GABA(A) receptors in adherent HEK293 cells
Devenish, S. O., Johnston, G. A. R., Chebib, M., & Hanrahan, J. R. (2018) · Protein Expression and Purification · doi:10.1016/j.pep.2018.09.012 · Cited by 1
Duan, H., Zhang, Y., Zhou, K., Wang, C., Qiu, D., & Hua, Y. (2017) · PubMed Central · doi:10.7499/j.issn.1008-8830.2017.04.022 · Cited by 1
Neurological Complications of Targeted Therapies
Chukwueke, U. N., Lee, E. Q., & Wen, P. Y. (2019) · Springer eBooks · doi:10.1007/978-3-030-23417-1_27 · Cited by 1
Petry, S. F., Kandula, N. D., Günther, S., Helker, C. S., Schagdarsurengin, U., & Linn, T. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1750-9190 · Cited by 1
The Medial Prefrontal Cortex (mPFC) and Addictions
Pérez-Rando, M., & Guirado, R. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_25-1 · Cited by 1
Detection of Sumo Modification of Endogenous Histone Deacetylase 2 (HDAC2) in Mammalian Cells
Citro, S., & Chiocca, S. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3667-0_2 · Cited by 1
Testing of neuroprotective compounds in a transgenic mouse model of Huntington's disease
Zádori, D. (2011) · doi:10.14232/phd.644 · Cited by 1
The Role of Histone Deacetylases in Cytokine Regulation in Human Gestational Tissues
Munro, S. K. (2013) · ResearchSpace (University of Auckland) · Cited by 1
Bricker, J. (2016) · QSpace (Queen's University Library) · Cited by 1
Genetic and epigenetic mechanisms in the aetiology of orofacial clefts
Alvizi, L. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2018.tde-12122017-172943 · Cited by 1
Aminpour, M., Miranda-Delgado, W. E., Wacker, S., Noskov, S., Houghton, M., Tyrrell, D. L., & Tuszyński, J. A. (2021) · Research Square · doi:10.21203/rs.3.rs-403464/v1 · Cited by 1
Dai, Q., Preuße, K., Yu, D., Kovall, R. A., Thorner, K., Lin, X., & Kopan, R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.26.591336 · Cited by 1
Epigenetic Biomarkers in Melanoma
Liu, S., Ren, S., Howell, P., & Riker, A. I. (2011) · Springer eBooks · doi:10.1007/978-1-60761-433-3_8
Molecular Basis of GATA-4 Expression During the Early Commitment Stage of Cardiomyogenesis
Yilbas, A. E. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-2730
Adwan, L. I. (2013) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-adwan-lina-2013
Cournoyer, P. (2008) · Archipel (Université du Québec à Montréal)
Epigenomic Analysis in Toxicology
Ushijima, T., Okochi‐Takada, E., & Takeshima, H. (2009) · Wiley eBooks · doi:10.1002/9780470744307.gat230
Histone Methyltransferases (GLP, G9a, SETDB1) and H3K9me2; Regulation in Psychiatric Disorders
Chase, K. A. (2012) · Figshare
Investigational Agents in Myeloid Disorders
Ravandi, F., & Cortes, J. E. (2004) · Advances in pharmacology · doi:10.1016/s1054-3589(04)51003-7
Wagner, J. M., Bug, G., & Jung, M. (2010) · Pharmazie in unserer Zeit · doi:10.1002/pauz.201000366
Analysis of functional domains required for hRad18 interactions with HHR6B and hUbc9
Ma, X. (2006) · University Library - University of Saskatchewan (University of Saskatchewan)
Beatriz, S., & Fagundes, R. H. D. S. (2008)
Cardoso, B. A. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Brichta, L. (2006) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Medizin, A. I., Direktor, Ä., & Kanz, L. (2012)
Autoimmune Diseases Associated with Epilepsy
Kürtüncü, M. (2015) · Journal of the Turkish Epilepsi Society · doi:10.5505/epilepsi.2015.15807
Researchattenuates TRAIL-induced apoptosis of pancreatic cancer cells
Schüler, S., Fritsche, P., Diersch, S., Arlt, A., Schmid, R. M., Saur, D., & Schneider, G. (2010)
(2013) · De Gruyter eBooks · doi:10.1515/9783034610896.295
Epigenetics in Development, Differentiation and Reprogramming
Salts, N., & Meshorer, E. (2016) · Springer eBooks · doi:10.1007/978-3-319-38882-3_18
Combination of erythromycin and dexamethasone improves corticosteroid
Sun, X., Li, Z., Zhang, Y., Zhou, G., Zhang, J., Deng, M., Bai, J., Liu, G., Li, M., & MacNee, W. (2015)
Lamparter, C. L. (2016) · QSpace (Queen's University Library)
Haque, F. N. (2010) · TSpace (University of Toronto)
Venkataramani, V. (2012) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1184
Agents and Approaches for Lytic Induction Therapy of Epstein-Barr Virus
van Rossen, T. M., Greijer, A. E., & Middeldorp, J. M. (2016)
Ataee, R., & Esmaeeli, H. (2017) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.22088/jbums.19.9.45
The influence of valproic acid and the role of cyclin D2 in prostate cancer
Morich, C. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5893
Targeting of Epigenetic Modifier EZH2 in Oropharyngeal Squamous Cell Carcinomas
Lindsay, C. (2018) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3cn6zf0h
Metadata
- Authors
- Krämer, O. H., Zhu, P., Ostendorff, H. P., Golebiewski, M., Tiefenbach, J., Peters, M. A., Brill, B., Groner, B., Bach, I., Heinzel, T., & Göttlicher, M.
- Affiliations
- Georg Speyer Haus (DE)
- Universität Hamburg (DE)
- Corresponding author
- Heinzel, Thorsten
- Göttlicher, Martin
- Venue
- The EMBO Journal
- Published
- 2003-07-01
- Volume
- 22
- Issue
- 13
- Pages
- 3411-3420
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC165640
- OpenAlex
- W2106775330
- Cited by
- 523
- References
- 41
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 14 · 2023: 13 · 2022: 25 · 2021: 16 · 2020: 19 · 2019: 20 · 2018: 27 · 2017: 26 · 2016: 30 · 2015: 19 · 2014: 27 · 2013: 33 · 2012: 29
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- valproic acid, HDAC2, histone deacetylase inhibitors, proteasomal degradation, ubiquitin-proteasome system, RLIM, polyubiquitination, trichostatin A, class I HDACs, protein turnover
- MeSH terms
- Animals, Base Sequence, Cells, Cultured, Cysteine Endopeptidases, Enzyme Inhibitors, Female, Hydrolysis, Hydroxamic Acids, Multienzyme Complexes, Valproic Acid, DNA Primers, Ubiquitin, Proteasome Endopeptidase Complex, Mice, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review